Literature DB >> 17236730

Antimycobacterial triterpenoids from Lantana hispida (Verbenaceae).

Adelina Jiménez-Arellanes1, Mariana Meckes, Javier Torres, Julieta Luna-Herrera.   

Abstract

As the Mycobacterium tuberculosis strains resistant to multiple drugs are increasing at an alarming rate, there is an urgent need for alternative anti-tuberculosis drugs. In a bioassay-guided search for antimycobacterial compounds obtained from higher plants, the study of the hexane extract from the aerial parts of Lantana hispida was performed and the biological activity of the plant products were tested against Mycobacterium tuberculosis H37Rv strain by microdilution alamar blue assay. Activity of the primary fractions led to the isolation of three pentacyclic triterpenoids with oleanane nucleous, together with beta-sitosterol. The molecular structures of the compounds were characterized as 3-acetoxy-22-(2'-methyl-2Z-butenyloxy)-12-oleanen-28-oic acid (1), 3-hydroxy-22 beta-(2'-methyl-2Z-butenoyloxy)-12-oleanen-28-oic acid (reduced lantadene A) (2) and oleanolic acid (3). MIC values for compounds 1 and 2 were 50 microg/ml, and for compound 3 the MIC=25 microg/ml.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17236730     DOI: 10.1016/j.jep.2006.11.033

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  20 in total

1.  Oleanolic and ursolic acids influence affect the expression of the cysteine regulon and the stress response in Escherichia coli.

Authors:  Anna M Grudniak; Anna Kurek; Jolanta Szarlak; Krystyna I Wolska
Journal:  Curr Microbiol       Date:  2011-01-09       Impact factor: 2.188

2.  Triterpenes from Olea europaea modulate in vitro ruminal fermentation.

Authors:  Lautaro R Cangiano; Darren D Henry; Francine M Ciriaco; Jose Carlos Quintela; Nicolas DiLorenzo; Ignacio R Ipharraguerre
Journal:  Transl Anim Sci       Date:  2022-05-06

Review 3.  Mexican Plants and Derivates Compounds as Alternative for Inflammatory and Neuropathic Pain Treatment-A Review.

Authors:  Geovanna N Quiñonez-Bastidas; Andrés Navarrete
Journal:  Plants (Basel)       Date:  2021-04-25

4.  Lantana montevidensis Briq improves the aminoglycoside activity against multiresistant Escherichia coli and Staphylococcus aureus.

Authors:  Erlanio O Sousa; Thiago S Almeida; Fabíola F G Rodrigues; Adriana R Campos; Sidney G Lima; José G M Costa
Journal:  Indian J Pharmacol       Date:  2011-04       Impact factor: 1.200

5.  Antiprotozoal and Antimycobacterial Activities of Pure Compounds from Aristolochia elegans Rhizomes.

Authors:  Adelina Jiménez-Arellanes; Rosalba León-Díaz; Mariana Meckes; Amparo Tapia; Gloria María Molina-Salinas; Julieta Luna-Herrera; Lilián Yépez-Mulia
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-16       Impact factor: 2.629

6.  Antimicrobial action of oleanolic acid on Listeria monocytogenes, Enterococcus faecium, and Enterococcus faecalis.

Authors:  Sejeong Kim; Heeyoung Lee; Soomin Lee; Yohan Yoon; Kyoung-Hee Choi
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

7.  Synergistic Effect of Oleanolic Acid on Aminoglycoside Antibiotics against Acinetobacter baumannii.

Authors:  Bora Shin; Woojun Park
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

8.  Antimycobacterial susceptibility testing methods for natural products research.

Authors:  Juan Gabriel Bueno Sánchez; Vladimir V Kouznetsov
Journal:  Braz J Microbiol       Date:  2010-06-01       Impact factor: 2.476

9.  Evaluating the anti Mycobacterium tuberculosis activity of Alpinia galanga (L.) Willd. axenically under reducing oxygen conditions and in intracellular assays.

Authors:  Pooja Gupta; Purva Bhatter; Desiree D'souza; Monica Tolani; Poonam Daswani; Pundarikakshudu Tetali; Tannaz Birdi
Journal:  BMC Complement Altern Med       Date:  2014-03-04       Impact factor: 3.659

10.  Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment.

Authors:  Adelina Jiménez-Arellanes; Julieta Luna-Herrera; Jorge Cornejo-Garrido; Sonia López-García; María Eugenia Castro-Mussot; Mariana Meckes-Fischer; Dulce Mata-Espinosa; Brenda Marquina; Javier Torres; Rogelio Hernández-Pando
Journal:  BMC Complement Altern Med       Date:  2013-10-07       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.